New data for darolutamide confirm safety and improved efficacy across subgroups of patients with metastatic hormone-sensitive prostate cancer (mHSPC) by 40% and 70% respectively, compared to placebo ...
ONCOLife proudly presents an exclusive interview with Dr. Joana Reis, Global Medical Affairs Lead, Breast Imaging, Radiology at Bayer. In this session, we explore how AI-driven advancements are ...
Ariceum Therapeutics announced that the US FDA has cleared its investigational new drug (IND) application to commence a Phase I/II clinical trial of its proprietary radiolabelled peptide, 225Ac-SSO110 ...
The FDA has approved Datroway® (datopotamab deruxtecan-dlnk) for adult patients with unresectable or metastatic HR-positive, HER2-negative breast cancer. This innovative TROP2-directed antibody-drug ...
The U.S. FDA has approved a novel combination therapy using Lumakras® (sotorasib) and Vectibix® (panitumumab) for adults with KRAS G12C-mutated metastatic colorectal cancer (mCRC). This innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback